Elad Travis

Associate

 travise@bennettjones.com
Education
The Hebrew University of Jerusalem, BA, 2005, Magna Cum Laude, Dean's List
The Hebrew University of Jerusalem, LLB, 2010, Magna Cum Laude
Bar Admissions
Israel, 2011
Ontario, 2018
Overview

Elad Travis practices corporate and securities law with particular emphasis on corporate finance, mergers and acquisitions, venture capital, private equity and corporate governance matters. Elad represents issuers and institutional investors in a wide range of financing transactions, including IPOs, RTOs, secondary offerings and private placements. Elad also acts for start-up companies in their efforts to raise capital in Canada.

Elad is co-head of the firm’s Canada - Israel Initiative, which advises Israeli companies looking to raise capital or make investments in Canada or to expand their businesses into Canada, as well as Canadian companies looking to invest in Israel or to partner with Israeli companies. Elad is one of the founders of "The Maple & Honey Forum" (LinkedIn), which serves as a premier platform for investing and growing businesses interested in leveraging the Canada-Israel relationship.

Prior to joining Bennett Jones, when practicing law in Israel, Elad focused on M&A transactions and competition law, representing a diverse set of clients from all areas of industry, in particular telecommunications and media as well as IT, natural resources exploration and pharmaceuticals.

Experience
•  Freed Developments Ltd. in its approximately $330-million acquisition of a portfolio of real property assets of including Horseshoe Valley Resort, Deerhurst Resort and some additional lands from Skyline Investments, together with the purchase of the portion of Muskoka Bay Resort it did not already own.
•  Cresco Labs, in its US$207-million acquisition of Bluma Wellness Inc. a vertically integrated operator in Florida.
•  Acquisition of IBI Group Inc. by Arcadis NV for $873 million via a plan of arrangement.
•  Israeli medical device company, in its proposed initial public offering on the TSX mainboard, for gross proceeds of approximately $50 million.
•  Israeli agri-tech company, in its proposed initial public offering on the TSX mainboard, for gross proceeds of approximately $25 million.
•  IT start-up company, in a Series A US$6 million financing.
•  Israeli food-tech company, in its proposed reverse takeover financing on the CSE, for gross proceeds of approximately $10 million.
•  NYSE-listed company, in the proposed spinout and listing of certain assets in a $1.2 billion initial public offering on the TSX.
•  Diversified, in its acquisition of  the business of Advanced Presentation Products.
•  Cresco Labs, in its $1.1-billion acquisition of Origin House, the largest public company acquisition in the history of the U.S. cannabis sector.